ConductScience.org, home

Trial · NCT05967052

Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

NCT05967052, Phase 2, Terminated, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation. Trials, record NCT05967052. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05967052

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
NCT number
NCT05967052
Status
Terminated
Phases
Phase 2
Enrollment
23 participants, actual
Lead sponsor
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Conditions
Chronic Fatigue Syndrome, COVID-19, Long Haul
Interventions
Pregabalin, Independent walking training, Placebo, Gradual movement therapy in the ward, Telerehabilitation, Psychotherapy
First posted
2023-08-01
Last updated
2026-06-17

Source ClinicalTrials.gov

Registered outcomes19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in fatigue intensity expressed as a difference in Multidimensional Fatigue Inventory-20 (MFI-20) score3 months and 6 monthsChange in fatigue intensity expressed as a difference in Multidimensional Fatigue Inventory-20 (MFI-20) score at 3 and 6 months of the study relative to the baseline score
PrimaryWalking distance as a difference in score from the 6 Minute Walking Test3 months and 6 monthsWalking distance as a difference in score from the 6 Minute Walking Test at 3 and 6 months compared to baseline
SecondaryChange in the level of satisfaction with life expressed in the form of the result of the Satisfaction with Life Scale (Juczyński)3 months and 6 months
Change in the level of satisfaction with life expressed in the form of the result of the Satisfaction with Life Scale (Juczyński) in the 3rd and 6th month of the study in relation to the result on the day of the study
SecondaryChange in the result obtained in the "Beck Depression Inventory (BDIII)" study3 months and 6 monthsChange in the result obtained in the "Beck Depression Inventory (BDIII)" study in the 3rd and 6th month of the study in relation to the result on the day of the study commencement.
SecondaryChange in the result obtained in the anxiety test - State and Trait Anxiety Inventory (STAI)3 months and 6 monthsChange in the result obtained in the anxiety test - State and Trait Anxiety Inventory (STAI) in the 3rd and 6th month of the study in relation to the result on the day of the study commencement.
SecondaryChange in the degree of acceptance of the disease assessed by the Acceptance of Illness Scale (Juczyński) i3 months and 6 months
Change in the degree of acceptance of the disease assessed by the Acceptance of Illness Scale (Juczyński) in the 3rd and 6th month of the study in relation to the result on the day of starting the study
SecondaryChange in the result of the CCT test3 months and 6 monthsChange in the result of the CCT test in the 3rd and 6th month of the study compared to the result on the day of starting the study.
SecondaryChange in neuropsychological assessment expressed by the change in the result of the Wisconsin Card Sorting Test (WCST)3 months and 6 months
Change in neuropsychological assessment expressed by the change in the result of the Wisconsin Card Sorting Test (WCST) in the 3rd and 6th month of the study compared to the result on the day of the study commencement.
SecondaryChange in the result of the RFFT test3 months and 6 monthsChange in the result of the RFFT test in the 3rd and 6th month of the study compared to the result on the day of starting the study.
SecondaryChange in the WAIS-R intelligence test result3 months and 6 monthsChange in the WAIS-R intelligence test result in the 3rd and 6th month of the study in relation to the result on the day of the study commencement

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Card Sorting Test (Berg)Secondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05967052

GET https://conductscience.org/api/trials/v1/NCT05967052/registered